Interferon-independent STAT1-mediated protective antiviral immunity
不依赖干扰素的STAT1介导的保护性抗病毒免疫
基本信息
- 批准号:9378819
- 负责人:
- 金额:$ 19.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-06-05 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAddressAnimalsAntiviral AgentsAntiviral ResponseB-LymphocytesC-KIT GeneCause of DeathCell Surface ReceptorsCell physiologyCell surfaceCellsCessation of lifeCidofovirDataDendritic CellsDermalDermisDevelopmentEventFailureFamilyFutureGene ExpressionGene TargetingGenesGoalsImmuneImmune responseImmune systemImmunityImmunizeIn VitroIndividualInfectionInfectious Skin DiseasesInsect BitesInterferon ReceptorInterferon-alphaInterferonsInvestigationJanus kinaseKnowledgeMediatingMediator of activation proteinModelingMolluscum ContagiosumMolluscum contagiosum virusMorbidity - disease rateMusMyxoma virusNatural ImmunityNatural Killer CellsNuclear TranslocationOryctolagus cuniculusPathogenesisPathway interactionsPatientsPeripheralPhenotypePhosphorylationPopulationPoxviridaePoxviridae InfectionsPredispositionProcessProtein FamilyProteinsProto-Oncogene Protein c-kitPublishingReceptor GeneReceptor SignalingRecruitment ActivityResistanceRoleRouteSTAT proteinSTAT1 geneSTAT2 geneSTAT3 geneSignal PathwaySignal TransductionSignaling MoleculeSiteSkinSmallpoxSmallpox VaccineSpecies SpecificitySurfaceSystemSystemic diseaseT-LymphocyteToll-like receptorsUp-RegulationVaccinesVaccinia virusVertebral columnViralViral VaccinesVirionVirusVirus DiseasesVirus ReplicationWild Type Mouseadaptive immune responseadaptive immunityantiviral immunitycell typecytokinein vivokillingsmacrophagemonocytemortalitynovelpreventprogramsreceptorreceptor bindingresponsevector vaccine
项目摘要
Viral skin infections are a significant cause of morbidity and mortality, with millions of individuals infected
worldwide with the poxvirus molluscum contagiosum virus (MCV). The related poxvirus Vaccinia virus (VACV)
was used to immunize hundreds of millions of people during the smallpox eradication program, and remains a
backbone of the many widely used viral vaccine vectors. The goal of the immune system is to restrict virus
spread until an adaptive immune response can be mounted that will clear the virus. Interferons (IFN) are a
family of protein cytokines that upregulate IFN stimulated genes (ISGs) to restrict virus replication and spread
and also activate the immune response via recruitment and activation of innate and effector immune cell
populations. The IFN family consists of Type I, II and III, each using separate receptors. All IFN receptors
signal through the Janus kinase (JAK)/ Signal Transducer and Activator of Transcription (STAT) pathway.
STAT1 signals via interactions with a number of other STAT proteins to transduce signals after receptor
binding of IFNs. After IFN receptor signaling, STAT1 is phosphorylated and subsequent nuclear translocation
leads to activation of a large number of ISGs. Deletion of STAT1 can dramatically reduce the immune response
to IFN in vitro and in vivo, and mice lacking STAT1 often succumb to systemic challenge with virus, including
VACV. Because of the tight linkage of IFN signaling and STAT1, the lethal phenotype of STAT1-deficient mice
upon virus challenge is most often assumed to be due to lack of the action of IFN. Our preliminary data
demonstrate that peripheral dermal infection with VACV, which is normally restricted to the site of infection,
causes death of mice lacking STAT1. Importantly, our preliminary data also indicate that ablation or depletion
of all three IFNs did not confer lethal susceptibility to dermal VACV, indicating that the lethal phenotype of
STAT1-deficient mice is likely a product of IFN-independent STAT1 signaling. A role for STAT1 has been
implicated in other signaling pathways, such as those mediated by CD117 (c-kit), IL-27R, IL-21R and a number
of Toll-Like Receptors (TLR). Our system, where we have a non-lethal infection in IFN-deficient animals, but a
lethal phenotype in STAT1-deficient mice, offers us a unique opportunity to probe the IFN-independent role of
STAT1 in protective antiviral immunity. We will examine the IFN-independent role of STAT1 in 2 Specific Aims.
In Aim 1, we will compare the host range of VACV, along with the innate and adaptive anti-VACV immune
responses, in mice lacking STAT1 or all three IFN receptors. Using this strategy we can identify IFN-
independent STAT1-mediated events that may be responsible for protection against lethal VACV challenge. In
Aim 2, we will examine STAT1 phosphorylation in mice lacking all three IFN receptors, as well as target genes
where expression in induced in a STAT1-dependent, IFN-independent manner. At the conclusion of the
proposed investigation we will have identified cells, immune processes and target genes that can provide the
basis for a future RO1 proposal investigating IFN-independent STAT1-mediated antiviral immunity.
病毒性皮肤感染是发病率和死亡率的重要原因,有数百万人感染
传染性软疣痘病毒(MCV)。牛痘病毒(Vaccinia Virus,VACV)
在天花根除计划中,它被用来为数亿人接种疫苗,
许多广泛使用的病毒疫苗载体的骨架。免疫系统的目标是限制病毒
直到适应性免疫反应可以安装,将清除病毒。干扰素(IFN)是一种
上调IFN刺激基因(ISG)以限制病毒复制和传播的蛋白质细胞因子家族
并且还通过募集和激活先天性和效应免疫细胞来激活免疫应答
人口。IFN家族由I型、II型和III型组成,每种都使用单独的受体。所有IFN受体
通过Janus激酶(JAK)/信号转导和转录激活因子(STAT)途径。
STAT 1通过与许多其他STAT蛋白相互作用来传递信号,以抑制受体后的信号。
干扰素的结合。在IFN受体信号传导后,STAT 1被磷酸化,随后发生核转位
导致大量ISG的激活。STAT 1的缺失可以显著降低免疫反应
缺乏STAT 1的小鼠经常死于病毒的全身性攻击,包括
VACV。由于IFN信号和STAT 1的紧密联系,STAT 1缺陷小鼠的致死表型
在病毒攻击时,最常被认为是由于缺乏IFN的作用。我们的初步数据
表明VACV的外周皮肤感染,通常限于感染部位,
导致缺乏STAT 1的小鼠死亡。重要的是,我们的初步数据还表明,消融或耗尽
所有三种IFN的致死性表型并不赋予对皮肤VACV的致死性易感性,表明
STAT 1缺陷小鼠可能是IFN-非依赖性STAT 1信号转导的产物。STAT 1的作用是
参与其他信号传导途径,如由CD 117(c-kit)、IL-27 R、IL-21 R和许多
Toll样受体(TLR)我们的系统,在IFN缺乏的动物中,我们有一个非致命的感染,但
STAT 1缺陷小鼠的致死表型,为我们提供了一个独特的机会,以探测IFN-依赖的作用,
STAT 1在保护性抗病毒免疫中的作用我们将在2个特定目标中研究STAT 1的IFN独立作用。
在目的1中,我们将比较VACV的宿主范围,沿着先天性和适应性抗VACV免疫
在缺乏STAT 1或所有三种IFN受体的小鼠中,使用这种策略,我们可以识别IFN-
独立的STAT 1介导的事件,可能负责保护免受致命的VACV攻击。在
目的2,我们将在缺乏所有三种IFN受体以及靶基因的小鼠中检测STAT 1的磷酸化
其中表达以STAT 1依赖性、IFN非依赖性方式诱导。结束时
建议的调查,我们将确定细胞,免疫过程和靶基因,可以提供
未来RO 1提案的基础是研究非干扰素依赖性STAT 1介导的抗病毒免疫。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher C Norbury其他文献
Christopher C Norbury的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christopher C Norbury', 18)}}的其他基金
How does Cytomegalovirus use interferon lambda for optimal spread
巨细胞病毒如何利用 lambda 干扰素实现最佳传播
- 批准号:
10552002 - 财政年份:2022
- 资助金额:
$ 19.34万 - 项目类别:
The effect of local virus infection upon cutaneous wound healing: the impact of virus-induced Type III IFNs
局部病毒感染对皮肤伤口愈合的影响:病毒诱导的III型干扰素的影响
- 批准号:
10433972 - 财政年份:2021
- 资助金额:
$ 19.34万 - 项目类别:
The effect of local virus infection upon cutaneous wound healing: the impact of virus-induced Type III IFNs
局部病毒感染对皮肤伤口愈合的影响:病毒诱导的III型干扰素的影响
- 批准号:
10217681 - 财政年份:2021
- 资助金额:
$ 19.34万 - 项目类别:
Analysis of the mechanism of HCMV cytoplasmic envelopment
HCMV胞质包膜机制分析
- 批准号:
10659275 - 财政年份:2017
- 资助金额:
$ 19.34万 - 项目类别:
Processing & Presentation of Ectromelia Virus to CD4+ T Lymphocytes - Asso Projec
加工
- 批准号:
7982871 - 财政年份:2009
- 资助金额:
$ 19.34万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 19.34万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 19.34万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 19.34万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 19.34万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 19.34万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 19.34万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 19.34万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 19.34万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 19.34万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 19.34万 - 项目类别:
Research Grant